Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

52.63
BATS BZX Real-Time Price
As of 12:24pm ET
 -0.59 / -1.11%
Today’s Change
35.72
Today|||52-Week Range
80.00
-32.98%
Year-to-Date
Biotechs Rise and Oil Falls
Aug 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close53.22
Today’s open53.41
Day’s range52.35 - 53.41
Volume5,236
Average volume (3 months)481,618
Market cap$1.9B
Dividend yield--
Data as of 12:24pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-57.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book31.25

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.48+2.57%
IRWDIronwood Pharmaceuti...-0.01-0.07%
IPXLImpax Laboratories I...+0.06+0.25%
ITCIIntra-Cellular Thera...+0.42+1.04%
Data as of 12:28pm ET, 08/29/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President &
Vice Chairman
Samir Chandrakant Patel
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs